Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-29 4:25 pm Unchanged | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund LP | 4,060,005 12.44% | 0 (Unchanged) | View |
| 2024-02-09 09:59 am Sale | 13G | LIFECORE BIOMEDICAL INC LFCR | DIMENSIONAL FUND ADVISORS LP | 1,940 0% | -1,755,604 (-99.89%) | View |
| 2024-01-04 4:00 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management LLC | 4,870,931 15.1% | 1,904,391 (+64.20%) | View |
| 2023-08-15 5:07 pm Sale | 13D | LIFECORE BIOMEDICAL INC LFCR | Cove Street Capital LLC | 1,583,440 5.15% | -791,325 (-33.32%) | View |
| 2023-07-07 4:35 pm Sale | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock Inc. BLK | 532,043 1.8% | -1,316,110 (-71.21%) | View |
| 2023-06-30 2:46 pm Purchase | 13G | LIFECORE BIOMEDICAL INC LFCR | Greenhaven Road Investment Management L.P. | 1,902,639 6.3% | 1,902,639 (New Position) | View |
| 2023-06-28 4:32 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund LP | 3,169,937 9.99% | 73,150 (+2.36%) | View |
| 2023-03-16 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,926,795 16.6% | 464,285 (+10.40%) | View |
| 2023-03-07 4:25 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 5,387,830 17.9% | 461,035 (+9.36%) | View |
| 2023-02-14 4:16 pm Sale | 13G | LIFECORE BIOMEDICAL INC LFCR | ISZO CAPITAL LP | 373,778 1.3% | -1,551,533 (-80.59%) | View |
| 2023-02-10 2:42 pm Sale | 13G | LIFECORE BIOMEDICAL INC LFCR | DIMENSIONAL FUND ADVISORS LP | 1,757,544 5.9% | -216,064 (-10.95%) | View |
| 2023-02-01 4:54 pm Sale | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock Inc. BLK | 1,848,153 6.2% | -98,305 (-5.05%) | View |
| 2023-01-12 5:13 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 4,926,795 16.6% | 2,362,271 (+92.11%) | View |
| 2023-01-12 4:23 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | Cove Street Capital LLC | 2,374,765 7.89% | 578,401 (+32.20%) | View |
| 2023-01-10 3:46 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund LP | 3,096,787 9.99% | 1,341,626 (+76.44%) | View |
| 2023-01-10 09:20 am Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management LLC | 2,966,540 9.99% | 38,450 (+1.31%) | View |
| 2022-12-02 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,462,510 14.8% | 884,805 (+24.73%) | View |
| 2022-09-12 4:36 pm Purchase | 13G | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund LP | 1,755,161 6% | 1,755,161 (New Position) | View |
| 2022-02-14 1:38 pm Sale | 13G | LIFECORE BIOMEDICAL INC LFCR | Russell Investments Group Ltd. | 208,428 0.71% | -2,383,126 (-91.96%) | View |
| 2022-02-14 12:36 pm Purchase | 13G | LIFECORE BIOMEDICAL INC LFCR | ISZO CAPITAL LP | 1,925,311 6.5% | 1,925,311 (New Position) | View |